Edition:
United States

Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

54.07USD
9 Dec 2016
Change (% chg)

$0.28 (+0.52%)
Prev Close
$53.79
Open
$53.57
Day's High
$54.59
Day's Low
$52.60
Volume
111,203
Avg. Vol
137,380
52-wk High
$58.15
52-wk Low
$37.71

ABAX.O

Chart for ABAX.O

About

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct... (more)

Overall

Beta: 0.85
Market Cap(Mil.): $1,218.47
Shares Outstanding(Mil.): 22.53
Dividend: 0.14
Yield (%): 1.04

Financials

  ABAX.O Industry Sector
P/E (TTM): 35.59 57.76 30.40
EPS (TTM): 1.52 -- --
ROI: 13.90 7.10 15.24
ROE: 14.26 10.71 16.58

BRIEF-Abaxis posts Q2 adj. earnings $0.34/shr from continuing operations

* Abaxis reports financial performance for the second quarter of fiscal 2017

Oct 25 2016

BRIEF-Abaxis Q1 earnings per share $0.30

* Board of directors has approved a $30 million increase to its existing share repurchase program, to a total of $54 million

Jul 21 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $112.26 +1.27
Roche Holding Ltd. (ROG.S) CHF227.80 +7.40
Roche Holding Ltd. (RO.S) CHF231.00 +4.90
Abbott Laboratories (ABT.N) $39.20 +0.52
Alere Inc (ALR.N) $37.58 +0.23
Alere Inc (ALR_pb.N) $322.00 -3.15
VCA Inc (WOOF.OQ) $64.68 +0.59
IDEXX Laboratories, Inc. (IDXX.OQ) $118.24 -0.55
Heska Corp (HSKA.OQ) $68.24 -0.33

Earnings vs. Estimates